Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02886234 · ClinicalTrials.gov registry record · NA

Health Improvement Project - Providence

A NA study of HIV, sponsored by The Miriam Hospital.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT02886234: Completed NA study of HIV, sponsored by The Miriam Hospital.

NCT02886234 is a NA study of HIV that has completed, run by The Miriam Hospital. The registered enrollment target is 50 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02886234, a NA study of HIV, has completed, sponsored by The Miriam Hospital.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study will investigate whether phone-delivered mindfulness training is feasible and acceptable for persons living with HIV and whether it may help them improve adherence to medications and reduce risky sexual behaviors.

Primary Outcome

Feasibility - as indicated by the number of patients attending at least 50% of sessions

Conditions Studied

Interventions

  • BEHAVIORAL Mindfulness Training (MT)
  • BEHAVIORAL Health Coaching (HC)

Study Locations (1)

Rhode Island

  • The Miriam Hospital - Providence

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2016-08
Est. Completion 2018-08
Phase NA
The Miriam Hospital

136 total trials

What the finished NCT02886234 record still lists

NCT02886234 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 440-participant average among 303 other HIV trials with a reported enrollment target (89% lower).

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness Training (MT) is the first listed.

NCT02886234 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT02886234 about?

NCT02886234 is a clinical study titled "Health Improvement Project - Providence". This study will investigate whether phone-delivered mindfulness training is feasible and acceptable for persons living with HIV and whether it may help them improve adherence to medications and reduce risky sexual behaviors.

What is the current status of trial NCT02886234?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-08. Estimated completion is 2018-08.

What conditions does trial NCT02886234 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT02886234?

The interventions under investigation include: Mindfulness Training (MT) (BEHAVIORAL), Health Coaching (HC) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02886234?

This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02886234 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02886234's enrollment target sits among peer trials

50 219th of 303 higher than 73 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

  • NCT01746836 · 50 participants · Phase 2

    Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02886234, the US trial registry maintained by the National Library of Medicine. NCT02886234 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.